Weber L W, Lebofsky M, Stahl B U, Smith S, Rozman K K
Section of Environmental Toxicology, GSF-Institut für Toxikologie, Oberschleissheim, FRG.
Toxicol Appl Pharmacol. 1995 Mar;131(1):155-62. doi: 10.1006/taap.1995.1057.
Male mice were treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) by gavage. C57BL/6J (C57) mice received 0.03 to 235 micrograms/kg, DBA/2J (DBA) mice 1 to 3295 micrograms/kg. On Day 8 after dosing blood was collected, and livers and kidneys were removed. Body weights and feed intake were not much affected until Day 8 after exposure. Hepatomegaly developed at doses above 3 and 97.5 micrograms/kg in C57 and DBA mice, respectively. Ethoxyresorufin O-deethylase activity was induced in liver with an ED50 of 1.1 and 16 micrograms/kg and in kidney with an ED50 of 65 and 380 micrograms/kg in C57 and DBA mice, respectively. The activity of phosphoenolpyruvate carboxykinase (PEPCK) in livers of both mouse strains was reduced over the entire dose range, displaying a plateau in the dose response at the onset of acute toxicity of TCDD. This enzyme activity was decreased by as much as 80% at the respective lethal doses. PEPCK activity in kidney was not affected. Glucose-6-phosphatase activity (G-6-Pase) in liver was altered only in the lethal dose range with a maximum reduction of about 50%. Serum glucose concentration was reduced over the entire dose range, but the reduction was significant only at doses in which G-6-Pase activity was affected, reaching levels as low as 3 mmol/liter in DBA mice. Tryptophan 2,3-dioxygenase activity was not lowered at any dose of TCDD in either mouse strain, and no increase in serum tryptophan levels was observed. Serum levels of thyroxine (T4) and triiodothyronine (T3) were dose dependently decreased over most of the dose range administered, with T3 levels exactly paralleling T4 levels in both mouse strains. It is concluded that TCDD causes acute toxicity in male C57 and DBA mice by a severe reduction of gluconeogenesis, but, in contrast to rats, it does not affect tryptophan homeostasis. Following administration of TCDD serum T3 levels in the mouse appear to correlate with T4 levels, whereas in the rat they are independent of each other.
通过灌胃法给雄性小鼠施用2,3,7,8-四氯二苯并对二恶英(TCDD)。C57BL/6J(C57)小鼠的给药剂量为0.03至235微克/千克,DBA/2J(DBA)小鼠为1至3295微克/千克。给药后第8天采集血液,并摘除肝脏和肾脏。在暴露后第8天之前,体重和采食量受影响不大。C57和DBA小鼠分别在剂量高于3微克/千克和97.5微克/千克时出现肝肿大。在C57和DBA小鼠中,肝脏中乙氧芴香豆素O-脱乙基酶活性被诱导,其半数有效剂量(ED50)分别为1.1微克/千克和16微克/千克,肾脏中该酶活性的ED50分别为65微克/千克和380微克/千克。在整个剂量范围内,两种小鼠品系肝脏中的磷酸烯醇式丙酮酸羧激酶(PEPCK)活性均降低,在TCDD急性毒性发作时,剂量反应呈平台期。在各自的致死剂量下,该酶活性降低多达80%。肾脏中的PEPCK活性未受影响。肝脏中的葡萄糖-6-磷酸酶活性(G-6-Pase)仅在致死剂量范围内发生改变,最大降低约50%。在整个剂量范围内血清葡萄糖浓度均降低,但仅在G-6-Pase活性受影响的剂量下降低显著,在DBA小鼠中可低至3毫摩尔/升。在两种小鼠品系中,任何剂量的TCDD均未降低色氨酸2,3-双加氧酶活性,且未观察到血清色氨酸水平升高。在施用TCDD后的大部分剂量范围内,血清甲状腺素(T4)和三碘甲状腺原氨酸(T3)水平呈剂量依赖性降低,在两种小鼠品系中,T3水平与T4水平完全平行。结论是,TCDD通过严重降低糖异生作用在雄性C57和DBA小鼠中引起急性毒性,但与大鼠不同,它不影响色氨酸稳态。施用TCDD后,小鼠血清T3水平似乎与T4水平相关,而在大鼠中它们相互独立。